Showing 1 - 5 results of 5 for search 'Meggan Bandrick', query time: 0.03s Refine Results
  1. 1
    One Dose of a Novel Vaccine Containing Two Genotypes of Porcine Circovirus (PCV2a and PCV2b) and <i>Mycoplasma hyopneumoniae</i> Conferred a Duration of Immunity of 23 Weeks

    One Dose of a Novel Vaccine Containing Two Genotypes of Porcine Circovirus (PCV2a and PCV2b) and <i>Mycoplasma hyopneumoniae</i> Conferred a Duration of Immunity of 23 Weeks by José Carlos Mancera Gracia, Megan Smutzer, Lucas Taylor, Mónica Balasch, Meggan Bandrick

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Safety of the Administration of an Inactivated PCV2a/PCV2b/<i>Mycoplasma Hyopneumoniae</i> Vaccine to Pregnant and Lactating Sows and Gilts

    Safety of the Administration of an Inactivated PCV2a/PCV2b/<i>Mycoplasma Hyopneumoniae</i> Vaccine to Pregnant and Lactating Sows and Gilts by Elena Pérez, Cristina Venegas-Vargas, Andrea Heinz, Megan Smutzer, Lucas P. Taylor, Yvette Diamondidis, Nevena Mangarova, Tara Hansen, José Angulo, Meggan Bandrick, Monica Balasch

    Published 2023-09-01
    Get full text
    Article
  3. 3
    Evaluation of the Efficacy of an S-INDEL PEDV Strain Administered to Pregnant Gilts against a Virulent Non-S-INDEL PEDV Challenge in Newborn Piglets

    Evaluation of the Efficacy of an S-INDEL PEDV Strain Administered to Pregnant Gilts against a Virulent Non-S-INDEL PEDV Challenge in Newborn Piglets by Loni Schumacher, Qi Chen, Lindsay Fredericks, Phillip Gauger, Meggan Bandrick, Marcia Keith, Luis Giménez-Lirola, Drew Magstadt, Wannarat Yim-im, Michael Welch, Jianqiang Zhang

    Published 2022-08-01
    Get full text
    Article
  4. 4
    Comparison of predicted T cell epitopes in porcine circovirus type 2 isolates from 2017 to 2021 and selected vaccines (EpiCC analysis) confirms the global relevance of a bivalent vaccine approach

    Comparison of predicted T cell epitopes in porcine circovirus type 2 isolates from 2017 to 2021 and selected vaccines (EpiCC analysis) confirms the global relevance of a bivalent v... by Dennis L. Foss, Andres H. Gutiérrez, Meggan Bandrick, Sudeep Perumbakkam, Anne S. De Groot, William D. Martin, Frances E. Terry, Alvaro Aldaz, James R.D. Allison, Jose Angulo

    Published 2023-06-01
    Get full text
    Article
  5. 5
    Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and <i>Mycoplasma hyopneumoniae</i> When Administered at 3 Weeks of Age

    Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and <i>Mycoplasma hyopneumoniae</i> When Administered at 3 Weeks of Age by Patricia Pleguezuelos, Marina Sibila, Carla Ramírez, Rosa López-Jiménez, Diego Pérez, Eva Huerta, Anna Maria Llorens, Mónica Pérez, Florencia Correa-Fiz, José Carlos Mancera Gracia, Lucas P. Taylor, Jennifer Smith, Meggan Bandrick, Stasia Borowski, Gillian Saunders, Joaquim Segalés, Sergio López-Soria, Maria Fort, Mónica Balasch

    Published 2022-12-01
    Get full text
    Article

Search Tools: